RETSEVMO 40 MG CPS DUR 56

What is the maximum co-payment for RETSEVMO?

If the insurance company contributes, the maximum co-payment is 48 205,18 Kč. The maximum pharmacy price is 70 412,65 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does RETSEVMO have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

22 207,47 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Selperkatinib je hrazen:
1) v monoterapii k léčbě dospělých pacientů s pokročilým nemalobuněčným karcinomem plic (NSCLC) s pozitivitou RET fúze, kteří nebyli dříve léčeni RET inhibitorem.
2) v monoterapii k léčbě dospělých a dospívajících pacientů ve věku 12 let a starších s pokročilým medulárním karcinomem štítné žlázy s mutací RET.
Pro obě indikace platí následující: Pacient má výkonnostní stav 0-2 dle ECOG. Léčba je hrazena do progrese onemocnění nebo nepřijatelné toxicity.
U pacientů s NSCLC nebyly prokázány aktivační mutace EGFR ani přestavba ALK.

Rychlý přehled

Dosage form Capsules
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Lék, jehož použití je s ohledem na veřejný zájem účelné koncentrovat do specializovaných pracovišť dle § 15 odst. 10 zákona o veřejném zdravotním pojištění. Lék je hrazen jako ZÚLP a to pouze z pracoviště, které má smlouvu se zdravotní poj…
Kdo může předepsat Prescription is not conditional on a medical specialization.
Složení More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek Ukončeno The latest report from the manufacturer is from 13. 3. 2026. Výroba byla ukončena s platností od 15. 5. 2026. The manufacturer lists medicines with the following code as a potential substitute: 0286223
Kód SÚKL 0255148

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe RETSEVMO?

Prescription is not conditional on a medical specialization.

What is the composition of RETSEVMO?

. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found v lokální importní databázi.

Which medicines are similar to RETSEVMO?

The medicine belongs to ATC group L01EX22. Název skupiny není v lokální importní databázi dostupný.

Who manufactures RETSEVMO?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 13. 3. 2026. Production was terminated with effect from 15. 5. 2026. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for RETSEVMO?

The medicine has code 0255148. Code details can be found here.

How many packs of RETSEVMO were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of RETSEVMO were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 22. 06. 2026

SIMILAR MEDICINES: